Synchronous Cancer
(1) Two or more histologically distinct simultaneously detected malignancies
(2) Two or more histologically distinct malignancies diagnosed during the same hospital admission
(3) Two or more histologically distinct malignancies arising in the same site, following each other in sequence by less than 2 months